Skip to main content
Equibles
KLRA logo

KLRA · Kailera Therapeutics, Inc. · Held by Funds

Track KLRA — free

Use KLRA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research KLRA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$12.85 -0.42 (-3.17%) At close · Oct 23
Russell 2000 member Rebalance outlook locked
Market Cap
$1.67B
Shares
129.64M
Volume · Oct 23 1.56M Avg daily vol (3M) 1M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of KLRA by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 3.91% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 0.29% 372,835
Index ETFs 3.63% 4,700,809
Active ETFs 0.12% 152,605
Active funds 7.48% 9,701,994
Unclassified 0.50% 653,137
All registered funds 12.02% 15,581,380
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding KLRA

125 fund positions
Fund Balance Value % of Fund Open
VANGUARD HEALTH CARE FUND 2,191,928 $37,131,260 0.10%
VANGUARD TOTAL STOCK MARKET INDEX FUND 1,180,411 $26,004,454 0.00%
iShares Russell 2000 ETF 1,163,223 $25,625,803 0.03%
T. Rowe Price Health Sciences Fund, Inc. 904,283 $19,921,354 0.17%
VANGUARD SMALL-CAP INDEX FUND 850,042 $18,726,425 0.01%
Fidelity Growth Company Fund 752,900 $17,271,526 0.02%
Columbia Small Cap Growth Fund 652,308 $14,963,946 0.41%
Select Biotechnology Portfolio 619,399 $14,209,013 0.27%
T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund 635,206 $13,993,588 0.14%
Eventide Healthcare & Life Sciences Fund 616,720 $13,586,342 0.76%
VANGUARD SMALL-CAP GROWTH INDEX FUND 487,994 $10,750,508 0.02%
BlackRock Health Sciences Opportunities Portfolio 464,174 $10,648,152 0.18%
VANGUARD EXTENDED MARKET INDEX FUND 476,221 $10,491,149 0.01%
Fidelity Blue Chip Growth Fund 587,097 $9,945,423 0.01%
Fidelity Small Cap Index Fund 503,961 $8,537,099 0.03%
T. Rowe Price New Horizons Fund, Inc. 367,899 $8,104,815 0.06%
Federated Hermes Kaufmann Small Cap Fund 403,600 $6,836,984 0.24%
iShares Russell 2000 Growth ETF 291,357 $6,418,595 0.04%
Fidelity Balanced Fund 261,900 $6,007,986 0.01%
Fidelity Growth Company K6 Fund 209,139 $4,797,649 0.02%
Fidelity Series Growth Company Fund 196,700 $4,512,298 0.02%
Roundhill GLP-1 & Weight Loss ETF 152,501 $3,359,597 6.21%
iShares Russell 2000 Value ETF 136,594 $3,009,166 0.02%
VANGUARD EXPLORER FUND 160,675 $2,721,835 0.01%
Franklin Biotechnology Discovery Fund 146,385 $2,479,762 0.21%
THE HARTFORD HEALTHCARE FUND 133,356 $2,259,051 0.29%
Fidelity Blue Chip Growth K6 Fund 120,322 $2,038,255 0.01%
Master Small Cap Index Series 86,313 $1,901,475 0.03%
Strategic Advisers U.S. Total Stock Fund 82,700 $1,897,138 0.00%
Schwab Small-Cap Index Fund 111,358 $1,886,405 0.02%
Fidelity Series Blue Chip Growth Fund 109,300 $1,851,542 0.01%
T.Rowe Price Small Cap Growth Portfolio 71,402 $1,572,986 0.14%
iShares Core S&P Total U.S. Stock Market ETF 61,730 $1,359,912 0.00%
T. Rowe Price Health Sciences Portfolio 55,664 $1,226,278 0.16%
Health Sciences Portfolio 55,117 $1,214,228 0.32%
BlackRock Health Sciences Term Trust 52,563 $1,157,963 0.11%
EQ/2000 Managed Volatility Portfolio 49,724 $1,095,420 0.03%
abrdn Healthcare Investors 49,509 $1,090,683 0.08%
Nuveen Small Cap Blend Index Fund 61,143 $1,035,762 0.03%
Transamerica T. Rowe Price Small Cap VP 45,963 $1,012,565 0.14%
Columbia Variable Portfolio - Small Company Growth Fund 44,521 $980,798 0.37%
BlackRock Health Sciences Trust 41,127 $906,028 0.16%
abrdn Healthcare Opportunities Fund 40,727 $897,216 0.11%
Fidelity Blue Chip Growth ETF 44,017 $745,648 0.01%
Health Sciences Trust 33,069 $728,510 0.29%
VANGUARD RUSSELL 2000 INDEX FUND 31,617 $725,294 0.00%
LVIP State Street Small-Cap Index Fund 32,900 $724,787 0.03%
Fidelity Small Cap Growth Index Fund 29,792 $656,318 0.04%
SMALL COMPANY GROWTH PORTFOLIO 28,752 $633,407 0.04%
EQ/Small Company Index Portfolio 27,370 $602,961 0.03%
Showing 1–50 of 125 positions
Key facts CIK 2096997 CUSIP 482931102 13F (30d) 10 filings 10 filers Visit website Investor relations